Categories: News

Sharecare announces inducement grants under Nasdaq Listing Rule 5635(c)(4)

ATLANTA, June 19, 2024 (GLOBE NEWSWIRE) — Sharecare (NASDAQ: SHCR), the digital health company that helps people manage all their health in one place, today announced that on June 14, 2024, its Board of Directors (the “Board”) adopted the Sharecare, Inc. 2024 Inducement Plan (the “Inducement Plan”), under which the Company may grant inducement equity awards outside of the Sharecare, Inc. 2021 Omnibus Incentive Plan, as amended. The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of the Company (or following a bona fide period of non-employment) as an inducement material to such individuals entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The Company allocated up to 5,000,000 shares of common stock of the Company to be subject to inducement equity awards under the Inducement Plan.

In addition, the Company announced that effective June 14, 2024, the Board has granted inducement equity awards under the Inducement Plan to five new employees. The five employees received a total of 3,389,285 restricted stock units, 1,889,285 of which are time-based restricted stock units (“RSUs”) and 1,500,000 of which are performance-based restricted stock units (“PSUs”). The RSUs vest over three or four years, subject to each employee’s continuous employment on each vesting date. The PSUs granted to one of the new employees provide for cliff vesting at the end of the three-year performance period, with the number of shares to be issued based on annual achievement of defined performance-based vesting conditions and will be subject to the employee’s continuous employment through the vesting date. Other terms of the RSU and PSU grants and any additional grants under the Inducement Plan are as determined by the Board or Compensation Committee and are as set forth in the Inducement Plan and applicable award agreements covering each grant.

For more information, visit investors.sharecare.com.

About Sharecare
Sharecare is the leading digital health company that helps people – no matter where they are in their health journey – unify and manage all their health in one place. Our comprehensive and data-driven virtual health platform is designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. Driven by our philosophy that we are all together better, at Sharecare, we are committed to supporting each individual through the lens of their personal health and making high-quality care more accessible and affordable for everyone. To learn more, visit www.sharecare.com.

Contacts:  
Media: pr@sharecare.com Investors: investors@sharecare.com

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

7 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

8 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

8 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

9 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

10 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

10 hours ago